Oncowitan logo (white)
  • About us
  • Our offer
    • Scientific writing & evaluation
    • Pharma projects
    • CDMO support
  • News
    • CDMO
    • Publications
  • [Gallery]

News

News-CDMO

R&D activities: CIR accreditation (Crédit Impôt Recherche) for years 2023-2025.

Christian Bailly (#Oncowitan) has obtained a CIR accreditation (Crédit Impôt Recherche) for three years, by the French Ministry of Higher Education and Research as a R&D consultant. This Research Tax Credit (CIR) agreement is valid for years 2023-2025. The expenses (30%) linked to your Research & Development (R&D) work that Read more…

By Christian Bailly, 2 years8 September 2023 ago
News-Publications

New publication: Discovery and properties of Yuexiandajisu diterpenoids from the Chinese medicinal preparation « Langdu »

(more…)

By Christian Bailly, 2 years10 July 2023 ago
News-Publications

New publication. Etoposide: a “killer on the road” for cancer, and a “rider on the storm” for HLH and MAS diseases (in memory of “The Doors”, Jim Morrison (1943–1971)).

(more…)

By Christian Bailly, 2 years10 June 2023 ago
News-Publications

New publication: Novel aldehyde-reactive small-molecule inhibitors of the immune checkpoint PD-L1 with antioxidant properties.

(more…)

By Christian Bailly, 3 years30 April 2023 ago
News-Publications

New publication: The tetraspanin protein CD81 as a molecular target for novel anticancer drugs.

(more…)

By Christian Bailly, 3 years17 April 2023 ago
News-Publications

New publication: A series of anticancer natural products, isolated from leafy liverworts (bryophytes).

(more…)

By Christian Bailly, 3 years31 March 2023 ago
News-Publications

New publication: Binding of camptothecin anticancer drugs to ribosomal proteins L11 and L15

(more…)

By Christian Bailly, 3 years27 February 2023 ago
News-Publications

New publication: The soluble form of the TIM-3 immune checkpoint as a biomarker of disease progression and therapeutic response.

(more…)

By Christian Bailly, 3 years5 February 2023 ago
News-Publications

New publication: Identification of an inhibitor of the PD-1/PD-L1 checkpoint in oncology.

(more…)

By Christian Bailly, 3 years22 January 2023 ago
News-Publications

New publication: A series of anticancer natural products identified as α-tubulin binders.

(more…)

By Christian Bailly, 3 years22 January 2023 ago

Posts navigation

Previous 1 2 3 4 … 10 Next
Search
  • Our partners
  • Contact
  • Legal notice
Hestia | Developed by ThemeIsle
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.